Thank you, Mr. Chairman.
First of all, I would like to welcome you before the committee. We are very happy to have you here today. As the chair said, we are about to undertake our review of the act.
At the outset, I should say that I agree with Mr. Godfrey and Ms. Cléroux in that part 5 seems to be a genuinely important aspect of the act. I would like to thank you for having committed yourselves to that review until now. It was indeed very important to do so.
I would like you to tell us whether Health Canada has completed its evaluation of the act.